Contact Information

Lizhi Chen represents domestic and international clients in a broad range of capital markets and M&A transactions, including U.S. initial public offerings (IPOs), SPAC and de-SPAC transactions, shelf offerings, private placements, going-private transactions, mergers and acquisitions, and securities regulatory compliance matters. She has extensive experience advising issuers, underwriters, investors, and other market participants, as well as drafting prospectuses, SEC filings, and complex transaction documents.

In addition to her transactional practice, Lizhi serves as an arbitrator and mediator with the Guangzhou Arbitration Commission in Guangzhou, China, where she has substantial experience handling and resolving commercial disputes. She also serves as Secretary-General of both the CIMAI Hong Kong International Arbitration and Mediation Institute Limited and the China-ASEAN (Macao) Arbitration Association.

Lizhi is also an adjunct mentor at the School of Law of Guangdong University of Foreign Studies in China and is a frequent lecturer and speaker on capital markets, cross-border investments, corporate governance, and international dispute resolution. 
 

Representative Experience

Any result the lawyer or law firm may have achieved on behalf of clients in other matters does not necessarily indicate similar results can be obtained for other clients. 

Initial Public Offerings
Represented issuers in:

  • Australian dairy-based nutritional product manufacturer’s IPO on NYSE.
  • Canadian agricultural service provider’s IPO on NASDAQ.  
  • Canadian smart farming solution service provider’s IPO on NASDAQ.
  • Chinese information technology service and products provider’s IPO on NASDAQ.
  • Canadian smart farming solution service provider’s IPO on NASDAQ.
  • Chinese pharmaceutical manufacturer and distributor’s IPO on NASDAQ.
  • Hong Kong broker dealer’s IPO on NASDAQ.
  • Hong Kong information technology solution provider’s IPO on NASDAQ.
  • Japanese broker of fine art and collectibles’ IPO on NYSE.
  • U.S. biotech company’s IPO on NASDAQ.
  • U.S. chemical technology company’s IPO on NYSE.
  • U.S. micro dramas production company’s IPO on NASDAQ.
  • U.S. transformers and electrical equipment’s IPO on NASDAQ.
  • U.S. vehicle export business operator’s IPO on NASDAQ.
  • Chinese leading home services platform company’s IPO on NASDAQ.
  • BingEx Limited (NASDAQ: FLX), a leading on-demand dedicated courier service provider in China, in its US$66 million initial public offering of American depositary shares and listing on the NASDAQ.
  • KE Holdings Inc. (NYSE: BEKE, HKEX: 2423), a leading TMT company engaged in housing transactions and related services, in its dual-primary listing by way of introduction on the HKEX.
  • Zhihu Inc. (NYSE: ZH, HKEX: 2390), a leading TMT online content company, in its US$106 million dual-primary listing of Class A ordinary shares on the HKEX.
  • YSB Inc. (HKEX: 9885), a leading pharmaceuticals sales platform, in its HK$316 million IPO on the HKEX.

Represented underwriters in:

  • Hong Kong game acceleration solution provider’s IPO on NASDAQ.
  • Hong Kong-based business-to-business contract logistics solution provider’s IPO on NASDAQ.
  • Chinese leading convenience store chain company’s IPO on NASDAQ.
  • Baozun Inc. (HKEX: 9991), a leading provider of e-commerce services and supply chain solutions, in its US$442 million secondary listing on the HKEX.
     

SPAC/de-SPAC Transactions 

  • Represented Prenetics Group Limited (NASDAQ: PRE), a genetic and diagnostic health testing company based in HK and UK, in its de-SPAC merger with Artisan Acquisition Corp., at an equity value of US$1.7 billion.
  • Represented ECARX Holdings, Inc. (NASDAQ: PRE), a global automotive technology provider, in its de-SPAC merger with COVA Acquisition Corp. at an enterprise value of US$3.8 billion.
  • Generation Asia I Acquisition Limited (NYSE: GAQ), a SPAC sponsor focused on the TMT, business services, and consumer sectors, in its US$200 million initial public offering on the NYSE.
  • Represented a German electric vehicle manufacturer in going public on NASDAQ via de-SPAC.

Mergers and Acquisitions

  • Represented Camelot Information Systems, a provider of IT services in China, in its sale of an 80% stake to Kingsoft Cloud (NASDAQ: KC), a cloud service company.
  • Represented a Nasdaq-listed China-based automotive service and supply chain technology provider in its acquisition of the remaining minority equity interest in a subsidiary. 
  • Represented a Nasdaq-listed Hong Kong construction and engineering services provider in its acquisition of a food and catering services business. 
  • Represented a US-listed pharmaceutical company in its going-private acquisition by an investor consortium.

Note Offerings

  • Represented Global SC Finance X Limited in a structured note offering to qualified institutional buyers and other eligible investors of $500,000,000 in principal amount of its Series 2025-1 Notes

SEC Filing and Compliance

  • Routinely represent U.S. public companies in their S-1/F-1, S-3/F-3, Reg D, Reg S, S-8, PIPE, ATM and private placement transactions.
  • Routinely represent U.S. public companies in their ongoing SEC public disclosure and compliance matters.

Investigation and Dispute Resolution

  • Represented a US-listed multinational pharmaceutical and biotechnology corporation in several FCPA compliance matters and internal investigations.
  • Represented a US-listed fintech company in a securities class action.
  • Represented a pharmaceutical investment company in an intellectual property case.
  • Regularly serve as an arbitrator in commercial dispute cases before arbitration commissions.
     

Thought Leadership

Publications

Languages

  • Mandarin
  • Cantonese